“…4 Although many recent studies have focused on lycorine, narciclasine and its analogues have been previously shown to be strong inhibitors of coronaviruses and RNA viruses possibly through interaction with eukaryotic translation elongation factors eEF1A, nucleocapsid and/or nucleic acids, as extensively reviewed in. 108 Earlier this year (2023), chemically synthetized trans -dihydrolycoricidine and dihydronarciclasine analog with ring-A mono-substituted C7-OH were also identified as inhibitors of SARS-CoV-2, 14 with IC 50 = 0.18 μM, CC 50 = 3.48 μM, IC 50 = 0.09 μM, and CC 50 = 1.92 μM. Le et al reported that 6α-hydroxyhippeastidine, 6β-hydroxyhippeastidine, 2- epi -lycorine, zephyranthine, and ungeremine isolated from Hymenocallis littoralis demonstrated weak anti-SARS-CoV-2 activity.…”